Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Haemonetics revenue
Haemonetics's revenue is $1.3 billion.
What is Haemonetics's revenue?
- Haemonetics's revenue growth from 2004 to 2023 is 241.26%.
- Haemonetics has 3,300 employees, and the revenue per employee ratio is $396,683.
- Haemonetics's peak quarterly revenue was $348.5M in 2024(q3).
- Haemonetics peak revenue was $1.3B in 2023.
- Haemonetics annual revenue for 2022 was 1.2B, 17.67% growth from 2021.
- Haemonetics annual revenue for 2023 was 1.3B, 12.01% growth from 2022.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Haemonetics historical revenue
Haemonetics's peak revenue was $1.3B in 2023. The peak quarterly revenue was $348.5M in 2024(q3).
Haemonetics's revenue increased from $383.6m in 2004 to $1.3B currently. That's a 241.26% change in annual revenue.
Haemonetics annual revenue
Haemonetics annual revenue over time
| Fiscal year / year | Haemonetics revenue |
|---|---|
| 2009 | $645.4M |
| 2010 | $676.7M |
| 2011 | $727.8M |
| 2012 | $892.0M |
| 2013 | $938.5M |
| 2014 | $910.4M |
| 2015 | $908.8M |
| 2016 | $886.1M |
| 2017 | $903.9M |
| 2018 | $967.6M |
| 2019 | $988.5M |
| 2020 | $870.5M |
| 2021 | $993.2M |
| 2022 | $1.2B |
| 2023 | $1.3B |
Rate Haemonetics' financial transparency
Haemonetics annual growth
Haemonetics saw the greatest revenue growth in 2008, when revenue increased by 32.98%.
Haemonetics had the lowest revenue growth in 2020, when revenue changed by -11.94%.
Haemonetics annual growth rate over time
| Year | Haemonetics growth |
|---|---|
| 2009 | 8%↑ |
| 2010 | 5%↑ |
| 2011 | 8%↑ |
| 2012 | 23%↑ |
| 2013 | 5%↑ |
| 2014 | -3%↓ |
| 2015 | -0%↓ |
| 2016 | -2%↓ |
| 2017 | 2%↑ |
| 2018 | 7%↑ |
| 2019 | 2%↑ |
| 2020 | -12%↓ |
| 2021 | 14%↑ |
| 2022 | 18%↑ |
| 2023 | 12%↑ |
Haemonetics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Haemonetics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $154.1M | $157.1M | $165.2M | $169.1M |
| 2010 | $163.0M | $166.8M | $176.8M | $170.0M |
| 2011 | $170.6M | $179.4M | $191.2M | $186.7M |
| 2012 | $176.5M | $218.2M | $247.4M | $249.9M |
| 2013 | $219.5M | $235.8M | $242.1M | $241.1M |
| 2014 | $224.5M | $227.6M | $231.8M | $226.5M |
| 2015 | $213.4M | $219.7M | $233.4M | $242.3M |
| 2016 | $210.0M | $220.3M | $227.8M | $228.1M |
| 2017 | $211.0M | $225.4M | $234.0M | $233.6M |
| 2018 | $229.3M | $241.6M | $247.4M | $249.3M |
| 2019 | $238.5M | $252.6M | $259.0M | $238.5M |
| 2020 | $195.6M | $209.5M | $240.4M | $225.0M |
| 2021 | $228.5M | $239.9M | $259.8M | $265.0M |
| 2022 | $261.5M | $297.5M | $305.3M | $304.4M |
| 2023 | $311.3M | $318.2M | $336.3M | $343.3M |
| 2024 | $336.2M | $345.5M | $348.5M | - |
Haemonetics jobs nearby
Do you work at Haemonetics?
Did Haemonetics meet its revenue projections?
Haemonetics financial information
| CEO | Christopher A. Simon |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 3,300 |
| Date Founded | 1971 |
| Headquarters | Braintree Town, Massachusetts |
| Number of Locations | 6 |
| Revenue | $1.3B |
| Net Income | $115,401,000 |
| Gross Proft | $691.5M (2023) |
| EBITDA | $122.6M (2020) |
| PE Ratio | 47.17 |
| Tax Rate | 0.2% |
| Market Capitalization | $5.5B |
| Total Assets | $1,934,825,000 |
| Ticker | HAE |
Haemonetics jobs you might like
Haemonetics financing
Haemonetics received early financing of $700.0M on 2018-06-18.
| Series | Round size | Date |
|---|---|---|
| Post-IPO Equity - Haemonetics | $10M | 05/2019 |
| Post-IPO Debt - Haemonetics | $700M | 06/2018 |
Haemonetics competitors
Haemonetics's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Haemonetics's smallest competitor is Catalent Pharma Solutions with revenue of $4.4B last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Hologic | $72,888 | $4.0B | 6,478 | 455 |
| Baxter International | $54,368 | $10.6B | 48,000 | 189 |
| Corning Incorporated | $77,020 | $13.1B | 51,500 | 663 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,879 |
| Danaher | $65,463 | $23.9B | 80,000 | 1,703 |
| United Therapeutics | $74,314 | $2.9B | 950 | 195 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Amgen | $93,349 | $33.4B | 22,000 | 584 |
| Ardent Technologies | $73,368 | $1.6M | 30 | - |
| Xerox | $40,954 | $6.2B | 24,700 | 614 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Haemonetics highest paying jobs
Zippia gives an in-depth look into the details of Haemonetics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Haemonetics. The employee data is based on information from people who have self-reported their past or current employments at Haemonetics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Haemonetics. The data presented on this page does not represent the view of Haemonetics and its employees or that of Zippia.
Haemonetics may also be known as or be related to Haemonetics, Haemonetics Corp and Haemonetics Corporation.